These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 12912863)

  • 1. Autocrine growth inhibition by transforming growth factor beta-1 (TGFbeta-1) in human neuroendocrine tumour cells.
    Wimmel A; Wiedenmann B; Rosewicz S
    Gut; 2003 Sep; 52(9):1308-16. PubMed ID: 12912863
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Keeping neuroendocrine cells in check: roles for TGFbeta, Smads, and menin?
    Dockray GJ
    Gut; 2003 Sep; 52(9):1237-9. PubMed ID: 12912851
    [No Abstract]   [Full Text] [Related]  

  • 3. Systematic analysis of the TGF-beta/Smad signalling pathway in the rhabdomyosarcoma cell line RD.
    Wang H; Yang GH; Bu H; Zhou Q; Guo LX; Wang SL; Ye L
    Int J Exp Pathol; 2003 Jun; 84(3):153-63. PubMed ID: 12974945
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting endogenous transforming growth factor beta receptor signaling in SMAD4-deficient human pancreatic carcinoma cells inhibits their invasive phenotype1.
    Subramanian G; Schwarz RE; Higgins L; McEnroe G; Chakravarty S; Dugar S; Reiss M
    Cancer Res; 2004 Aug; 64(15):5200-11. PubMed ID: 15289325
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TGF-beta1 acts as a tumor suppressor of human malignant keratinocytes independently of Smad 4 expression and ligand-induced G(1) arrest.
    Paterson IC; Davies M; Stone A; Huntley S; Smith E; Pring M; Eveson JW; Robinson CM; Parkinson EK; Prime SS
    Oncogene; 2002 Feb; 21(10):1616-24. PubMed ID: 11896591
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective inhibition of activin receptor-like kinase 5 signaling blocks profibrotic transforming growth factor beta responses in skin fibroblasts.
    Mori Y; Ishida W; Bhattacharyya S; Li Y; Platanias LC; Varga J
    Arthritis Rheum; 2004 Dec; 50(12):4008-21. PubMed ID: 15593186
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suppression of tumorigenesis and induction of p15(ink4b) by Smad4/DPC4 in human pancreatic cancer cells.
    Peng B; Fleming JB; Breslin T; Grau AM; Fojioka S; Abbruzzese JL; Evans DB; Ayers D; Wathen K; Wu T; Robertson KD; Chiao PJ
    Clin Cancer Res; 2002 Nov; 8(11):3628-38. PubMed ID: 12429655
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The BRAFV600E oncogene induces transforming growth factor beta secretion leading to sodium iodide symporter repression and increased malignancy in thyroid cancer.
    Riesco-Eizaguirre G; Rodríguez I; De la Vieja A; Costamagna E; Carrasco N; Nistal M; Santisteban P
    Cancer Res; 2009 Nov; 69(21):8317-25. PubMed ID: 19861538
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disruption of TGFbeta signaling pathways in human pancreatic cancer cells.
    Simeone DM; Pham T; Logsdon CD
    Ann Surg; 2000 Jul; 232(1):73-80. PubMed ID: 10862198
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Keratinocyte growth inhibition by high-dose epidermal growth factor is mediated by transforming growth factor beta autoinduction: a negative feedback mechanism for keratinocyte growth.
    Yamasaki K; Toriu N; Hanakawa Y; Shirakata Y; Sayama K; Takayanagi A; Ohtsubo M; Gamou S; Shimizu N; Fujii M; Miyazono K; Hashimoto K
    J Invest Dermatol; 2003 Jun; 120(6):1030-7. PubMed ID: 12787131
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Growth factor receptor expression in human gastroenteropancreatic neuroendocrine tumours.
    Wulbrand U; Wied M; Zöfel P; Göke B; Arnold R; Fehmann H
    Eur J Clin Invest; 1998 Dec; 28(12):1038-49. PubMed ID: 9893017
    [TBL] [Abstract][Full Text] [Related]  

  • 12. beta-Catenin and TGFbeta signalling cooperate to maintain a mesenchymal phenotype after FosER-induced epithelial to mesenchymal transition.
    Eger A; Stockinger A; Park J; Langkopf E; Mikula M; Gotzmann J; Mikulits W; Beug H; Foisner R
    Oncogene; 2004 Apr; 23(15):2672-2680. PubMed ID: 14755243
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dissecting the role of TGF-beta type I receptor/ALK5 in pancreatic ductal adenocarcinoma: Smad activation is crucial for both the tumor suppressive and prometastatic function.
    Schniewind B; Groth S; Sebens Müerköster S; Sipos B; Schäfer H; Kalthoff H; Fändrich F; Ungefroren H
    Oncogene; 2007 Jul; 26(33):4850-62. PubMed ID: 17297450
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The adaptor molecule Disabled-2 links the transforming growth factor beta receptors to the Smad pathway.
    Hocevar BA; Smine A; Xu XX; Howe PH
    EMBO J; 2001 Jun; 20(11):2789-801. PubMed ID: 11387212
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression and regulation of intracellular SMAD signaling in scleroderma skin fibroblasts.
    Mori Y; Chen SJ; Varga J
    Arthritis Rheum; 2003 Jul; 48(7):1964-78. PubMed ID: 12847691
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transforming growth factor beta receptor family ligands inhibit hepatocyte growth factor synthesis and secretion from astrocytoma cells.
    Chattopadhyay N; T-Felt Hansen J; Godbole MM; Brown EM
    Brain Res Mol Brain Res; 2004 Feb; 121(1-2):146-50. PubMed ID: 14969747
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RAS/ERK modulates TGFbeta-regulated PTEN expression in human pancreatic adenocarcinoma cells.
    Chow JY; Quach KT; Cabrera BL; Cabral JA; Beck SE; Carethers JM
    Carcinogenesis; 2007 Nov; 28(11):2321-7. PubMed ID: 17638924
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microsatellite unstable colorectal cancer cell lines with truncating TGFbetaRII mutations remain sensitive to endogenous TGFbeta.
    Baker K; Raut P; Jass JR
    J Pathol; 2007 Nov; 213(3):257-65. PubMed ID: 17893910
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autocrine TGFbeta signaling mediates vitamin D3 analog-induced growth inhibition in breast cells.
    Yang L; Yang J; Venkateswarlu S; Ko T; Brattain MG
    J Cell Physiol; 2001 Sep; 188(3):383-93. PubMed ID: 11473365
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel dominant negative Smad2 mutation in a TGFbeta resistant human carcinoma cell line.
    Tsang KJ; Tsang D; Brown TN; Crowe DL
    Anticancer Res; 2002; 22(1A):13-9. PubMed ID: 12017275
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.